Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Hyper-reactions to radiotherapy

Name: Hyper-reactions to radiotherapy
Uploaded: 2009-11-03T00:00:00+00:00
Description: Dirk De Ruysscher, from the University Hospital Maastricht, Netherlands, discusses his work studying the genetics of patients and predicting reaction to radiotherapy, in order to improve efficiency. Talking at ECCO 15- ESMO 34, Berlin 2009.

ECCO 15 - ESMO 34

20 - 24 Sep 2009

Published: 3 Nov 2009

Rating:

Save

Dirk De Ruysscher - University Hospital Maastricht, Netherlands

Dirk De Ruysscher, from the University Hospital Maastricht, Netherlands, discusses his work studying the genetics of patients and predicting reaction to radiotherapy, in order to improve efficiency. Talking at ECCO 15- ESMO 34, Berlin 2009.

Related Videos

Improving African representation in breast cancer genomics

Dr Ricardo Pinto - i3S, Porto, Portugal

19 Jan 2026

New classification for identifying HR myeloma based on cytogenetic abnormalities

Dr Jill Corre - IUCT Oncopole, Toulouse, France

29 Oct 2024

ASCO 2024: Lung cancer highlights

Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas Girard and Dr Anna Minchom

26 Jun 2024

Multiple myeloma in a resource constrained setting

Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda

22 Feb 2024

The evolving paradigm in management of Multiple Myeloma

D Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India

5 Dec 2023

A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC patients

Dr Jones Nauseef - Weill Cornell Medicine, New York City, USA

$A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC patients ( Dr Jones Nauseef - Weill Cornell Medicine, New York City, USA )$

20 Apr 2023

Precision oncology: Present and future in breast cancer

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

28 Mar 2023

Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer

Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK

$Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer ( Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK )$

17 Feb 2023

Abiraterone acetate/prednisone + apalutimide and ADT with post-op SRT may improve PFS and MFS after prostatectomy

Prof Paul L Nguyen - Dana-Farber Cancer Institute, Boston, USA

16 Feb 2023

Hyper-reactions to radiotherapy

ECCO 15 - ESMO 34

Related Videos

More from ecancer